Interestingly, the treatment of cancer cells with non-cytotoxic doses of PADI4 and KDM6B inhibitors induced similar transcriptomic profiles, regulating genes related to cell adhesion and the extracellular matrix, which was associated with decreased capacity of cancer cells to invade and migrate in the in vitro model. Here, KDM6B is linked to cancer.